ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,879,777 | -18.6% | 2,455,555 | +11.3% | 0.03% | -25.7% |
| Q2 2023 | $4,763,999 | -8.3% | 2,205,555 | -10.8% | 0.04% | -22.2% |
| Q1 2023 | $5,193,623 | +72.0% | 2,473,154 | +79.4% | 0.04% | +45.2% |
| Q4 2022 | $3,019,456 | -6.7% | 1,378,747 | +27.8% | 0.03% | -18.4% |
| Q3 2022 | $3,236,000 | +17.6% | 1,078,747 | +10.9% | 0.04% | +22.6% |
| Q2 2022 | $2,752,000 | -32.4% | 972,326 | +27.8% | 0.03% | -31.1% |
| Q1 2022 | $4,070,000 | -19.3% | 760,798 | +12.7% | 0.04% | -22.4% |
| Q4 2021 | $5,042,000 | -49.0% | 674,975 | -38.0% | 0.06% | -52.5% |
| Q3 2021 | $9,885,000 | +58.9% | 1,088,664 | -14.6% | 0.12% | +69.4% |
| Q2 2021 | $6,221,000 | +42.1% | 1,274,747 | +29.6% | 0.07% | +28.6% |
| Q1 2021 | $4,377,000 | +33.9% | 983,594 | +16.7% | 0.06% | +21.7% |
| Q4 2020 | $3,269,000 | +34.5% | 842,554 | +11.9% | 0.05% | +24.3% |
| Q3 2020 | $2,431,000 | -24.6% | 752,646 | +3.7% | 0.04% | -24.5% |
| Q2 2020 | $3,223,000 | +55.9% | 725,984 | -1.7% | 0.05% | +19.5% |
| Q1 2020 | $2,067,000 | – | 738,288 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |